rotation.to
Following this device: dark.
Free account
rotation.to
Sign in / Request free access
Appearance
Following this device: dark.
Drag a card by its title · ⚙ to size, swap or remove

Who

Kathy Johnson Weiler

Director

Company insider

Files Form 4 as: Director, Axogen; Chief Comm. & Growth Officer, American Well.

Every Form 4 they filed

In numbers

Trades disclosed
33
Buys
0
Sells
8
Bought
$0
Sold
$4.6M
Companies
2
Companies where not an officer
1
First trade
1 Jun 2023
Last trade
7 Aug 2026
Last filed
11 Aug 2026

Companies traded

Where they are an officer
AMWL American WellOfficer · Business Services · last 2 Dec 20240 buys · 4 sells
Everywhere else they filed: board seats, 10% stakes, other companies
AXGN AxogenDirector · Medical Devices · last 7 Aug 20260 buys · 4 sells

Activity over time

1 Nov 2024 – 1 Oct 2026
10Nov 24May 25Nov 25Apr 26Oct 26

Buys above the line, sells below, each month.

Every trade

TradedCompanyWhatAmount
7 Aug 2026filed 11 Aug 2026AXGN AxogenMedical DevicesSEC FORM 4 Sold$641K14,150 at $45.30filing
7 Aug 2026filed 11 Aug 2026AXGN AxogenMedical DevicesSEC FORM 4 Sold$641K14,150 at $45.30filing
24 Jun 2026filed 26 Jun 2026AXGN Axogenoption or derivative · Medical DevicesSEC FORM 4 Code A—4,392 at $0.00filing
24 Jun 2026filed 26 Jun 2026AXGN Axogenoption or derivative · Medical DevicesSEC FORM 4 Code A—4,392 at $0.00filing
19 Jun 2026filed 23 Jun 2026AXGN AxogenMedical DevicesSEC FORM 4 Code M—14,150 at $0.00filing
19 Jun 2026filed 23 Jun 2026AXGN Axogenoption or derivative · Medical DevicesSEC FORM 4 Code M—14,150 at $0.00filing
19 Jun 2026filed 23 Jun 2026AXGN Axogenoption or derivative · Medical DevicesSEC FORM 4 Code M—14,150 at $0.00filing
19 Jun 2026filed 23 Jun 2026AXGN AxogenMedical DevicesSEC FORM 4 Code M—14,150 at $0.00filing
7 May 2026filed 8 May 2026AXGN AxogenMedical DevicesSEC FORM 4 Code M$114K16,344 at $6.95filing
7 May 2026filed 8 May 2026AXGN AxogenMedical DevicesSEC FORM 4 Sold$721K16,344 at $44.09filing
7 May 2026filed 8 May 2026AXGN Axogenoption or derivative · Medical DevicesSEC FORM 4 Code M—16,344 at $0.00filing
7 May 2026filed 8 May 2026AXGN Axogenoption or derivative · Medical DevicesSEC FORM 4 Code M—16,344 at $0.00filing
7 May 2026filed 8 May 2026AXGN AxogenMedical DevicesSEC FORM 4 Code M$114K16,344 at $6.95filing
7 May 2026filed 8 May 2026AXGN AxogenMedical DevicesSEC FORM 4 Sold$721K16,344 at $44.09filing
16 Dec 2025filed 17 Dec 2025AXGN Axogenoption or derivative · Medical DevicesSEC FORM 4 Code M—18,248 at $0.00filing
16 Dec 2025filed 17 Dec 2025AXGN Axogenoption or derivative · Medical DevicesSEC FORM 4 Code M—21,825 at $0.00filing
16 Dec 2025filed 17 Dec 2025AXGN AxogenMedical DevicesSEC FORM 4 Code M$128K18,248 at $7.04filing
16 Dec 2025filed 17 Dec 2025AXGN AxogenMedical DevicesSEC FORM 4 Code M$152K21,825 at $6.95filing
16 Dec 2025filed 17 Dec 2025AXGN AxogenMedical DevicesSEC FORM 4 Sold$539K18,248 at $29.55filing
16 Dec 2025filed 17 Dec 2025AXGN AxogenMedical DevicesSEC FORM 4 Sold$645K21,825 at $29.55filing

Sectors

Health Care4
Industrials4

Buys in green, sells in red, by the company’s sector.

Related people

Mark HirschhornChief Financial Officer · Chief Financial Officer at American Well, filing Form 4 there in the last year
Paul Francis McNeiceChief Accounting Officer · Chief Accounting Officer at American Well, filing Form 4 there in the last year
Phyllis GotlibPresident, International · President, International at American Well, filing Form 4 there in the last year
Dmitry ZamanskyChief Product & Tech. Officer · Chief Product & Tech. Officer at American Well, filing Form 4 there in the last year
Derek RossDirector · Director at American Well, filing Form 4 there in the last year
Joseph A. TyndallDirector · Also traded AXGN in the last 90 days
Amy McBride WendellDirector · Also traded AXGN in the last 90 days
Marc A. BeganEVP & General Counsel · Also traded AXGN in the last 90 days